nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—ALB—atherosclerosis	0.354	1	CbGaD
Rufinamide—ALB—Rosuvastatin—atherosclerosis	0.0897	0.402	CbGbCtD
Rufinamide—CYP3A4—Rosuvastatin—atherosclerosis	0.0281	0.126	CbGbCtD
Rufinamide—CYP3A4—Ezetimibe—atherosclerosis	0.0281	0.126	CbGbCtD
Rufinamide—CYP3A4—Simvastatin—atherosclerosis	0.0261	0.117	CbGbCtD
Rufinamide—CYP3A4—Pravastatin—atherosclerosis	0.0256	0.115	CbGbCtD
Rufinamide—CYP3A4—Lovastatin—atherosclerosis	0.0256	0.115	CbGbCtD
Rufinamide—Gastrointestinal symptom NOS—Niacin—atherosclerosis	0.00434	0.0231	CcSEcCtD
Rufinamide—Bone disorder—Ezetimibe—atherosclerosis	0.00323	0.0171	CcSEcCtD
Rufinamide—Bone disorder—Niacin—atherosclerosis	0.00283	0.015	CcSEcCtD
Rufinamide—Nocturia—Pravastatin—atherosclerosis	0.00271	0.0144	CcSEcCtD
Rufinamide—Urine output increased—Niacin—atherosclerosis	0.00231	0.0123	CcSEcCtD
Rufinamide—Breast disorder—Rosuvastatin—atherosclerosis	0.0023	0.0122	CcSEcCtD
Rufinamide—Influenza—Rosuvastatin—atherosclerosis	0.0022	0.0117	CcSEcCtD
Rufinamide—Bronchitis—Rosuvastatin—atherosclerosis	0.00212	0.0112	CcSEcCtD
Rufinamide—Polyuria—Niacin—atherosclerosis	0.00211	0.0112	CcSEcCtD
Rufinamide—Breast disorder—Ezetimibe—atherosclerosis	0.00191	0.0102	CcSEcCtD
Rufinamide—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00189	0.0101	CcSEcCtD
Rufinamide—Haematuria—Rosuvastatin—atherosclerosis	0.00187	0.00994	CcSEcCtD
Rufinamide—Influenza—Lovastatin—atherosclerosis	0.00187	0.00991	CcSEcCtD
Rufinamide—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00186	0.00986	CcSEcCtD
Rufinamide—Sinusitis—Rosuvastatin—atherosclerosis	0.00184	0.00978	CcSEcCtD
Rufinamide—Influenza—Ezetimibe—atherosclerosis	0.00183	0.00972	CcSEcCtD
Rufinamide—Diplopia—Pravastatin—atherosclerosis	0.00183	0.00969	CcSEcCtD
Rufinamide—Rhinitis—Rosuvastatin—atherosclerosis	0.00177	0.00938	CcSEcCtD
Rufinamide—Bronchitis—Simvastatin—atherosclerosis	0.00168	0.00891	CcSEcCtD
Rufinamide—Nasopharyngitis—Pravastatin—atherosclerosis	0.00163	0.00867	CcSEcCtD
Rufinamide—Infestation—Ezetimibe—atherosclerosis	0.00163	0.00866	CcSEcCtD
Rufinamide—Infestation NOS—Ezetimibe—atherosclerosis	0.00163	0.00866	CcSEcCtD
Rufinamide—Influenza—Niacin—atherosclerosis	0.0016	0.00851	CcSEcCtD
Rufinamide—Influenza—Pravastatin—atherosclerosis	0.00158	0.00838	CcSEcCtD
Rufinamide—Sinusitis—Lovastatin—atherosclerosis	0.00156	0.00829	CcSEcCtD
Rufinamide—Mental disorder—Rosuvastatin—atherosclerosis	0.00154	0.0082	CcSEcCtD
Rufinamide—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00154	0.00819	CcSEcCtD
Rufinamide—Bronchitis—Niacin—atherosclerosis	0.00154	0.00818	CcSEcCtD
Rufinamide—Sinusitis—Ezetimibe—atherosclerosis	0.00153	0.00813	CcSEcCtD
Rufinamide—Dysuria—Pravastatin—atherosclerosis	0.00148	0.00783	CcSEcCtD
Rufinamide—Sinusitis—Simvastatin—atherosclerosis	0.00146	0.00775	CcSEcCtD
Rufinamide—Weight decreased—Pravastatin—atherosclerosis	0.00143	0.00758	CcSEcCtD
Rufinamide—Immune system disorder—Ezetimibe—atherosclerosis	0.00132	0.00703	CcSEcCtD
Rufinamide—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00132	0.00701	CcSEcCtD
Rufinamide—Sinusitis—Pravastatin—atherosclerosis	0.00132	0.00701	CcSEcCtD
Rufinamide—Rhinitis—Niacin—atherosclerosis	0.00129	0.00683	CcSEcCtD
Rufinamide—Mental disorder—Ezetimibe—atherosclerosis	0.00128	0.00681	CcSEcCtD
Rufinamide—Malnutrition—Ezetimibe—atherosclerosis	0.00128	0.00677	CcSEcCtD
Rufinamide—Rhinitis—Pravastatin—atherosclerosis	0.00127	0.00672	CcSEcCtD
Rufinamide—Back pain—Lovastatin—atherosclerosis	0.00126	0.00668	CcSEcCtD
Rufinamide—Infection—Rosuvastatin—atherosclerosis	0.00124	0.0066	CcSEcCtD
Rufinamide—Back pain—Ezetimibe—atherosclerosis	0.00123	0.00655	CcSEcCtD
Rufinamide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00123	0.00652	CcSEcCtD
Rufinamide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00123	0.00651	CcSEcCtD
Rufinamide—Vision blurred—Lovastatin—atherosclerosis	0.00123	0.00651	CcSEcCtD
Rufinamide—Mental disorder—Simvastatin—atherosclerosis	0.00122	0.0065	CcSEcCtD
Rufinamide—Tremor—Lovastatin—atherosclerosis	0.00122	0.00647	CcSEcCtD
Rufinamide—Eye disorder—Niacin—atherosclerosis	0.0012	0.00637	CcSEcCtD
Rufinamide—Anaemia—Ezetimibe—atherosclerosis	0.00118	0.00626	CcSEcCtD
Rufinamide—Cardiac disorder—Pravastatin—atherosclerosis	0.00117	0.00622	CcSEcCtD
Rufinamide—Vertigo—Lovastatin—atherosclerosis	0.00117	0.0062	CcSEcCtD
Rufinamide—Leukopenia—Lovastatin—atherosclerosis	0.00116	0.00618	CcSEcCtD
Rufinamide—Vision blurred—Simvastatin—atherosclerosis	0.00115	0.00609	CcSEcCtD
Rufinamide—Tremor—Simvastatin—atherosclerosis	0.00114	0.00605	CcSEcCtD
Rufinamide—Insomnia—Rosuvastatin—atherosclerosis	0.00113	0.00601	CcSEcCtD
Rufinamide—Anaemia—Simvastatin—atherosclerosis	0.00112	0.00597	CcSEcCtD
Rufinamide—Malnutrition—Niacin—atherosclerosis	0.00112	0.00593	CcSEcCtD
Rufinamide—Anxiety—Lovastatin—atherosclerosis	0.0011	0.00586	CcSEcCtD
Rufinamide—Dyspepsia—Rosuvastatin—atherosclerosis	0.0011	0.00585	CcSEcCtD
Rufinamide—Vertigo—Simvastatin—atherosclerosis	0.00109	0.0058	CcSEcCtD
Rufinamide—Leukopenia—Simvastatin—atherosclerosis	0.00109	0.00578	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00108	0.00572	CcSEcCtD
Rufinamide—Constipation—Rosuvastatin—atherosclerosis	0.00107	0.00569	CcSEcCtD
Rufinamide—Infection—Lovastatin—atherosclerosis	0.00105	0.0056	CcSEcCtD
Rufinamide—Vision blurred—Niacin—atherosclerosis	0.00105	0.00559	CcSEcCtD
Rufinamide—Thrombocytopenia—Lovastatin—atherosclerosis	0.00104	0.00552	CcSEcCtD
Rufinamide—Vision blurred—Pravastatin—atherosclerosis	0.00104	0.0055	CcSEcCtD
Rufinamide—Infection—Ezetimibe—atherosclerosis	0.00103	0.00549	CcSEcCtD
Rufinamide—Anxiety—Simvastatin—atherosclerosis	0.00103	0.00548	CcSEcCtD
Rufinamide—Tremor—Pravastatin—atherosclerosis	0.00103	0.00547	CcSEcCtD
Rufinamide—Nervous system disorder—Ezetimibe—atherosclerosis	0.00102	0.00542	CcSEcCtD
Rufinamide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00102	0.00541	CcSEcCtD
Rufinamide—Anaemia—Pravastatin—atherosclerosis	0.00102	0.0054	CcSEcCtD
Rufinamide—Anorexia—Lovastatin—atherosclerosis	0.00101	0.00537	CcSEcCtD
Rufinamide—Skin disorder—Ezetimibe—atherosclerosis	0.00101	0.00537	CcSEcCtD
Rufinamide—Vertigo—Niacin—atherosclerosis	0.001	0.00533	CcSEcCtD
Rufinamide—Leukopenia—Niacin—atherosclerosis	0.001	0.00531	CcSEcCtD
Rufinamide—Vertigo—Pravastatin—atherosclerosis	0.000988	0.00524	CcSEcCtD
Rufinamide—Infection—Simvastatin—atherosclerosis	0.000986	0.00524	CcSEcCtD
Rufinamide—Leukopenia—Pravastatin—atherosclerosis	0.000984	0.00523	CcSEcCtD
Rufinamide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000972	0.00516	CcSEcCtD
Rufinamide—Insomnia—Lovastatin—atherosclerosis	0.00096	0.0051	CcSEcCtD
Rufinamide—Anorexia—Simvastatin—atherosclerosis	0.000946	0.00502	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000944	0.00501	CcSEcCtD
Rufinamide—Insomnia—Ezetimibe—atherosclerosis	0.000941	0.005	CcSEcCtD
Rufinamide—Dyspepsia—Lovastatin—atherosclerosis	0.000934	0.00496	CcSEcCtD
Rufinamide—Anxiety—Pravastatin—atherosclerosis	0.000933	0.00495	CcSEcCtD
Rufinamide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000922	0.0049	CcSEcCtD
Rufinamide—Decreased appetite—Lovastatin—atherosclerosis	0.000922	0.0049	CcSEcCtD
Rufinamide—Dyspepsia—Ezetimibe—atherosclerosis	0.000916	0.00486	CcSEcCtD
Rufinamide—Fatigue—Lovastatin—atherosclerosis	0.000915	0.00486	CcSEcCtD
Rufinamide—Constipation—Lovastatin—atherosclerosis	0.000907	0.00482	CcSEcCtD
Rufinamide—Decreased appetite—Ezetimibe—atherosclerosis	0.000905	0.0048	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000898	0.00477	CcSEcCtD
Rufinamide—Asthenia—Rosuvastatin—atherosclerosis	0.000898	0.00477	CcSEcCtD
Rufinamide—Insomnia—Simvastatin—atherosclerosis	0.000898	0.00477	CcSEcCtD
Rufinamide—Fatigue—Ezetimibe—atherosclerosis	0.000897	0.00476	CcSEcCtD
Rufinamide—Infection—Pravastatin—atherosclerosis	0.000891	0.00473	CcSEcCtD
Rufinamide—Constipation—Ezetimibe—atherosclerosis	0.00089	0.00473	CcSEcCtD
Rufinamide—Pruritus—Rosuvastatin—atherosclerosis	0.000886	0.0047	CcSEcCtD
Rufinamide—Skin disorder—Niacin—atherosclerosis	0.000885	0.0047	CcSEcCtD
Rufinamide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000879	0.00466	CcSEcCtD
Rufinamide—Dyspepsia—Simvastatin—atherosclerosis	0.000874	0.00464	CcSEcCtD
Rufinamide—Anorexia—Niacin—atherosclerosis	0.000869	0.00461	CcSEcCtD
Rufinamide—Decreased appetite—Simvastatin—atherosclerosis	0.000863	0.00458	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000857	0.00455	CcSEcCtD
Rufinamide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000857	0.00455	CcSEcCtD
Rufinamide—Fatigue—Simvastatin—atherosclerosis	0.000856	0.00454	CcSEcCtD
Rufinamide—Anorexia—Pravastatin—atherosclerosis	0.000855	0.00454	CcSEcCtD
Rufinamide—Constipation—Simvastatin—atherosclerosis	0.000849	0.00451	CcSEcCtD
Rufinamide—Dizziness—Rosuvastatin—atherosclerosis	0.000828	0.0044	CcSEcCtD
Rufinamide—Insomnia—Niacin—atherosclerosis	0.000824	0.00438	CcSEcCtD
Rufinamide—Insomnia—Pravastatin—atherosclerosis	0.000812	0.00431	CcSEcCtD
Rufinamide—Somnolence—Niacin—atherosclerosis	0.00081	0.0043	CcSEcCtD
Rufinamide—Dyspepsia—Niacin—atherosclerosis	0.000802	0.00426	CcSEcCtD
Rufinamide—Decreased appetite—Niacin—atherosclerosis	0.000792	0.00421	CcSEcCtD
Rufinamide—Dyspepsia—Pravastatin—atherosclerosis	0.00079	0.00419	CcSEcCtD
Rufinamide—Rash—Rosuvastatin—atherosclerosis	0.000789	0.00419	CcSEcCtD
Rufinamide—Dermatitis—Rosuvastatin—atherosclerosis	0.000789	0.00419	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000787	0.00418	CcSEcCtD
Rufinamide—Headache—Rosuvastatin—atherosclerosis	0.000784	0.00416	CcSEcCtD
Rufinamide—Hypersensitivity—Lovastatin—atherosclerosis	0.000782	0.00415	CcSEcCtD
Rufinamide—Decreased appetite—Pravastatin—atherosclerosis	0.00078	0.00414	CcSEcCtD
Rufinamide—Fatigue—Pravastatin—atherosclerosis	0.000774	0.00411	CcSEcCtD
Rufinamide—Constipation—Pravastatin—atherosclerosis	0.000767	0.00407	CcSEcCtD
Rufinamide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000767	0.00407	CcSEcCtD
Rufinamide—Asthenia—Lovastatin—atherosclerosis	0.000761	0.00404	CcSEcCtD
Rufinamide—Pruritus—Lovastatin—atherosclerosis	0.000751	0.00399	CcSEcCtD
Rufinamide—Asthenia—Ezetimibe—atherosclerosis	0.000747	0.00396	CcSEcCtD
Rufinamide—Nausea—Rosuvastatin—atherosclerosis	0.000744	0.00395	CcSEcCtD
Rufinamide—Pruritus—Ezetimibe—atherosclerosis	0.000736	0.00391	CcSEcCtD
Rufinamide—Hypersensitivity—Simvastatin—atherosclerosis	0.000731	0.00388	CcSEcCtD
Rufinamide—Diarrhoea—Lovastatin—atherosclerosis	0.000726	0.00385	CcSEcCtD
Rufinamide—Asthenia—Simvastatin—atherosclerosis	0.000712	0.00378	CcSEcCtD
Rufinamide—Diarrhoea—Ezetimibe—atherosclerosis	0.000712	0.00378	CcSEcCtD
Rufinamide—Pruritus—Simvastatin—atherosclerosis	0.000702	0.00373	CcSEcCtD
Rufinamide—Dizziness—Lovastatin—atherosclerosis	0.000702	0.00373	CcSEcCtD
Rufinamide—Dizziness—Ezetimibe—atherosclerosis	0.000688	0.00365	CcSEcCtD
Rufinamide—Diarrhoea—Simvastatin—atherosclerosis	0.000679	0.00361	CcSEcCtD
Rufinamide—Vomiting—Lovastatin—atherosclerosis	0.000675	0.00358	CcSEcCtD
Rufinamide—Hypersensitivity—Niacin—atherosclerosis	0.000671	0.00357	CcSEcCtD
Rufinamide—Rash—Lovastatin—atherosclerosis	0.000669	0.00355	CcSEcCtD
Rufinamide—Dermatitis—Lovastatin—atherosclerosis	0.000668	0.00355	CcSEcCtD
Rufinamide—Headache—Lovastatin—atherosclerosis	0.000665	0.00353	CcSEcCtD
Rufinamide—Vomiting—Ezetimibe—atherosclerosis	0.000662	0.00351	CcSEcCtD
Rufinamide—Hypersensitivity—Pravastatin—atherosclerosis	0.000661	0.00351	CcSEcCtD
Rufinamide—Dizziness—Simvastatin—atherosclerosis	0.000656	0.00348	CcSEcCtD
Rufinamide—Rash—Ezetimibe—atherosclerosis	0.000656	0.00348	CcSEcCtD
Rufinamide—Dermatitis—Ezetimibe—atherosclerosis	0.000656	0.00348	CcSEcCtD
Rufinamide—Asthenia—Niacin—atherosclerosis	0.000654	0.00347	CcSEcCtD
Rufinamide—Headache—Ezetimibe—atherosclerosis	0.000652	0.00346	CcSEcCtD
Rufinamide—Pruritus—Niacin—atherosclerosis	0.000645	0.00342	CcSEcCtD
Rufinamide—Asthenia—Pravastatin—atherosclerosis	0.000644	0.00342	CcSEcCtD
Rufinamide—Pruritus—Pravastatin—atherosclerosis	0.000635	0.00337	CcSEcCtD
Rufinamide—Vomiting—Simvastatin—atherosclerosis	0.000631	0.00335	CcSEcCtD
Rufinamide—Nausea—Lovastatin—atherosclerosis	0.00063	0.00335	CcSEcCtD
Rufinamide—Rash—Simvastatin—atherosclerosis	0.000626	0.00332	CcSEcCtD
Rufinamide—Dermatitis—Simvastatin—atherosclerosis	0.000625	0.00332	CcSEcCtD
Rufinamide—Diarrhoea—Niacin—atherosclerosis	0.000624	0.00331	CcSEcCtD
Rufinamide—Headache—Simvastatin—atherosclerosis	0.000622	0.0033	CcSEcCtD
Rufinamide—Nausea—Ezetimibe—atherosclerosis	0.000618	0.00328	CcSEcCtD
Rufinamide—Diarrhoea—Pravastatin—atherosclerosis	0.000614	0.00326	CcSEcCtD
Rufinamide—Dizziness—Niacin—atherosclerosis	0.000603	0.0032	CcSEcCtD
Rufinamide—Dizziness—Pravastatin—atherosclerosis	0.000593	0.00315	CcSEcCtD
Rufinamide—Nausea—Simvastatin—atherosclerosis	0.00059	0.00313	CcSEcCtD
Rufinamide—Vomiting—Niacin—atherosclerosis	0.000579	0.00308	CcSEcCtD
Rufinamide—Rash—Niacin—atherosclerosis	0.000575	0.00305	CcSEcCtD
Rufinamide—Dermatitis—Niacin—atherosclerosis	0.000574	0.00305	CcSEcCtD
Rufinamide—Headache—Niacin—atherosclerosis	0.000571	0.00303	CcSEcCtD
Rufinamide—Vomiting—Pravastatin—atherosclerosis	0.000571	0.00303	CcSEcCtD
Rufinamide—Rash—Pravastatin—atherosclerosis	0.000566	0.003	CcSEcCtD
Rufinamide—Dermatitis—Pravastatin—atherosclerosis	0.000565	0.003	CcSEcCtD
Rufinamide—Headache—Pravastatin—atherosclerosis	0.000562	0.00298	CcSEcCtD
Rufinamide—Nausea—Niacin—atherosclerosis	0.000541	0.00287	CcSEcCtD
Rufinamide—Nausea—Pravastatin—atherosclerosis	0.000533	0.00283	CcSEcCtD
Rufinamide—SCN1A—Developmental Biology—MAPK3—atherosclerosis	4.81e-05	0.000205	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MAPK3—atherosclerosis	4.81e-05	0.000205	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VWF—atherosclerosis	4.79e-05	0.000204	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LTA4H—atherosclerosis	4.75e-05	0.000203	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCG8—atherosclerosis	4.75e-05	0.000203	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MAPK3—atherosclerosis	4.74e-05	0.000202	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SERPINE1—atherosclerosis	4.72e-05	0.000201	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PLTP—atherosclerosis	4.71e-05	0.000201	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TNF—atherosclerosis	4.71e-05	0.000201	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—APOA1—atherosclerosis	4.7e-05	0.000201	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TGFB1—atherosclerosis	4.67e-05	0.000199	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TGFB1—atherosclerosis	4.67e-05	0.000199	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL6—atherosclerosis	4.67e-05	0.000199	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—atherosclerosis	4.6e-05	0.000196	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—F7—atherosclerosis	4.57e-05	0.000195	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—AKT1—atherosclerosis	4.53e-05	0.000193	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—atherosclerosis	4.52e-05	0.000193	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—atherosclerosis	4.52e-05	0.000193	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NOS3—atherosclerosis	4.51e-05	0.000192	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—F2—atherosclerosis	4.48e-05	0.000191	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	4.36e-05	0.000186	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—atherosclerosis	4.36e-05	0.000186	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—atherosclerosis	4.36e-05	0.000186	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	4.34e-05	0.000185	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	4.31e-05	0.000184	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	4.29e-05	0.000183	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.21e-05	0.00018	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCG8—atherosclerosis	4.08e-05	0.000174	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LTA4H—atherosclerosis	4.08e-05	0.000174	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAT—atherosclerosis	4.07e-05	0.000174	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.03e-05	0.000172	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—CETP—atherosclerosis	4e-05	0.000171	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CXCL8—atherosclerosis	4e-05	0.000171	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP9—atherosclerosis	3.98e-05	0.00017	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—IL6—atherosclerosis	3.97e-05	0.000169	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NFKB1—atherosclerosis	3.94e-05	0.000168	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	3.93e-05	0.000168	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AKT1—atherosclerosis	3.86e-05	0.000165	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.81e-05	0.000163	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.81e-05	0.000162	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL6—atherosclerosis	3.8e-05	0.000162	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—IL6—atherosclerosis	3.8e-05	0.000162	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.76e-05	0.00016	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCG1—atherosclerosis	3.75e-05	0.00016	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	3.73e-05	0.000159	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL6—atherosclerosis	3.71e-05	0.000158	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—atherosclerosis	3.66e-05	0.000156	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—IL6—atherosclerosis	3.65e-05	0.000156	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—IL6—atherosclerosis	3.65e-05	0.000156	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MMP9—atherosclerosis	3.62e-05	0.000154	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NFKB1—atherosclerosis	3.58e-05	0.000153	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KNG1—atherosclerosis	3.58e-05	0.000153	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—atherosclerosis	3.58e-05	0.000153	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAUR—atherosclerosis	3.54e-05	0.000151	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—STAT3—atherosclerosis	3.54e-05	0.000151	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—FABP4—atherosclerosis	3.53e-05	0.000151	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LCAT—atherosclerosis	3.53e-05	0.000151	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.53e-05	0.00015	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MAPK8—atherosclerosis	3.52e-05	0.00015	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—IL6—atherosclerosis	3.52e-05	0.00015	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—IL6—atherosclerosis	3.52e-05	0.00015	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—atherosclerosis	3.51e-05	0.00015	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—atherosclerosis	3.5e-05	0.000149	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—IL6—atherosclerosis	3.47e-05	0.000148	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOA4—atherosclerosis	3.47e-05	0.000148	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLG—atherosclerosis	3.46e-05	0.000148	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP7A1—atherosclerosis	3.4e-05	0.000145	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.39e-05	0.000145	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MAPK3—atherosclerosis	3.38e-05	0.000144	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—atherosclerosis	3.37e-05	0.000144	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—atherosclerosis	3.37e-05	0.000144	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SOD1—atherosclerosis	3.32e-05	0.000142	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TGFB1—atherosclerosis	3.28e-05	0.00014	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—atherosclerosis	3.25e-05	0.000139	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—atherosclerosis	3.25e-05	0.000138	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—atherosclerosis	3.25e-05	0.000138	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCG1—atherosclerosis	3.23e-05	0.000138	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STAT3—atherosclerosis	3.22e-05	0.000137	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF2—atherosclerosis	3.15e-05	0.000135	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP27A1—atherosclerosis	3.15e-05	0.000134	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MAPK3—atherosclerosis	3.07e-05	0.000131	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—atherosclerosis	3.06e-05	0.000131	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—APOB—atherosclerosis	3.06e-05	0.000131	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LCAT—atherosclerosis	3.03e-05	0.000129	CbGpPWpGaD
Rufinamide—ALB—Metabolism—FABP4—atherosclerosis	3.03e-05	0.000129	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—PLG—atherosclerosis	3e-05	0.000128	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALOX5AP—atherosclerosis	2.98e-05	0.000127	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOA2—atherosclerosis	2.98e-05	0.000127	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PLA2G2A—atherosclerosis	2.98e-05	0.000127	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALOX15—atherosclerosis	2.98e-05	0.000127	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TGFB1—atherosclerosis	2.98e-05	0.000127	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOA4—atherosclerosis	2.98e-05	0.000127	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCG5—atherosclerosis	2.95e-05	0.000126	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP7A1—atherosclerosis	2.93e-05	0.000125	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LPA—atherosclerosis	2.85e-05	0.000121	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PRKCG—atherosclerosis	2.84e-05	0.000121	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.79e-05	0.000119	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CD36—atherosclerosis	2.78e-05	0.000119	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.77e-05	0.000118	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—BGN—atherosclerosis	2.76e-05	0.000118	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOA5—atherosclerosis	2.73e-05	0.000116	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP27A1—atherosclerosis	2.7e-05	0.000115	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.7e-05	0.000115	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.66e-05	0.000114	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	2.65e-05	0.000113	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PLA2G1B—atherosclerosis	2.63e-05	0.000112	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.6e-05	0.000111	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	2.57e-05	0.000109	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOA2—atherosclerosis	2.56e-05	0.000109	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PLA2G2A—atherosclerosis	2.56e-05	0.000109	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ALOX5AP—atherosclerosis	2.56e-05	0.000109	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ALOX15—atherosclerosis	2.56e-05	0.000109	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PDGFB—atherosclerosis	2.56e-05	0.000109	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PLTP—atherosclerosis	2.54e-05	0.000108	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALOX5—atherosclerosis	2.54e-05	0.000108	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MMP1—atherosclerosis	2.53e-05	0.000108	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCG5—atherosclerosis	2.53e-05	0.000108	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.53e-05	0.000108	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—atherosclerosis	2.47e-05	0.000106	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LPA—atherosclerosis	2.45e-05	0.000104	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CAV1—atherosclerosis	2.43e-05	0.000104	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	2.43e-05	0.000104	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—APOA1—atherosclerosis	2.42e-05	0.000103	CbGpPWpGaD
Rufinamide—ALB—Metabolism—BGN—atherosclerosis	2.37e-05	0.000101	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	2.36e-05	0.000101	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.35e-05	0.0001	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOA5—atherosclerosis	2.34e-05	0.0001	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—F2—atherosclerosis	2.31e-05	9.86e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS2—atherosclerosis	2.28e-05	9.74e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—atherosclerosis	2.28e-05	9.73e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.28e-05	9.72e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NAMPT—atherosclerosis	2.27e-05	9.71e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LIPC—atherosclerosis	2.26e-05	9.64e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PLA2G1B—atherosclerosis	2.26e-05	9.63e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—atherosclerosis	2.25e-05	9.58e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOC3—atherosclerosis	2.25e-05	9.58e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.24e-05	9.54e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LDLR—atherosclerosis	2.23e-05	9.53e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.23e-05	9.52e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CG—atherosclerosis	2.21e-05	9.44e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.21e-05	9.43e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.21e-05	9.41e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.2e-05	9.4e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.2e-05	9.4e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CETP—atherosclerosis	2.18e-05	9.3e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ALOX5—atherosclerosis	2.18e-05	9.3e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.1e-05	8.95e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SCARB1—atherosclerosis	2.09e-05	8.91e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—atherosclerosis	2.07e-05	8.84e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF1—atherosclerosis	2.03e-05	8.64e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.01e-05	8.59e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HMGCR—atherosclerosis	1.97e-05	8.41e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NAMPT—atherosclerosis	1.96e-05	8.34e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.94e-05	8.29e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LIPC—atherosclerosis	1.94e-05	8.29e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOC3—atherosclerosis	1.93e-05	8.24e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SERPINE1—atherosclerosis	1.92e-05	8.21e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LDLR—atherosclerosis	1.92e-05	8.19e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CETP—atherosclerosis	1.87e-05	8e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS3—atherosclerosis	1.84e-05	7.83e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SCARB1—atherosclerosis	1.8e-05	7.66e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCA1—atherosclerosis	1.76e-05	7.5e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.74e-05	7.43e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HMGCR—atherosclerosis	1.7e-05	7.23e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—FABP4—atherosclerosis	1.64e-05	6.99e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LCAT—atherosclerosis	1.64e-05	6.99e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.64e-05	6.99e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOA4—atherosclerosis	1.61e-05	6.86e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.58e-05	6.74e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.53e-05	6.52e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCA1—atherosclerosis	1.51e-05	6.45e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HMOX1—atherosclerosis	1.51e-05	6.43e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.46e-05	6.23e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOB—atherosclerosis	1.44e-05	6.16e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTM1—atherosclerosis	1.41e-05	6e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.38e-05	5.9e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOA2—atherosclerosis	1.38e-05	5.9e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.38e-05	5.9e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.38e-05	5.9e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LPL—atherosclerosis	1.38e-05	5.89e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.37e-05	5.83e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GPX1—atherosclerosis	1.35e-05	5.74e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—atherosclerosis	1.32e-05	5.64e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LPA—atherosclerosis	1.32e-05	5.63e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CD36—atherosclerosis	1.31e-05	5.59e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HMOX1—atherosclerosis	1.3e-05	5.53e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BGN—atherosclerosis	1.28e-05	5.45e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOA5—atherosclerosis	1.27e-05	5.4e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MAPK3—atherosclerosis	1.25e-05	5.34e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—atherosclerosis	1.24e-05	5.3e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOB—atherosclerosis	1.24e-05	5.3e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARA—atherosclerosis	1.22e-05	5.2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.22e-05	5.2e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB1—atherosclerosis	1.21e-05	5.18e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTM1—atherosclerosis	1.21e-05	5.15e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LPL—atherosclerosis	1.19e-05	5.06e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AGT—atherosclerosis	1.18e-05	5.03e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.18e-05	5.02e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPX1—atherosclerosis	1.16e-05	4.93e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOE—atherosclerosis	1.16e-05	4.93e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CAV1—atherosclerosis	1.15e-05	4.89e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOA1—atherosclerosis	1.14e-05	4.88e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CD36—atherosclerosis	1.13e-05	4.81e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—atherosclerosis	1.07e-05	4.55e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.06e-05	4.5e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LIPC—atherosclerosis	1.05e-05	4.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARA—atherosclerosis	1.05e-05	4.47e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CG—atherosclerosis	1.04e-05	4.45e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOC3—atherosclerosis	1.04e-05	4.45e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LDLR—atherosclerosis	1.04e-05	4.42e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AGT—atherosclerosis	1.01e-05	4.33e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CETP—atherosclerosis	1.01e-05	4.32e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARG—atherosclerosis	1.01e-05	4.3e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOE—atherosclerosis	9.94e-06	4.24e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—INS—atherosclerosis	9.88e-06	4.21e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CAV1—atherosclerosis	9.85e-06	4.2e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOA1—atherosclerosis	9.82e-06	4.19e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.69e-06	4.13e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HMGCR—atherosclerosis	9.15e-06	3.9e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALB—atherosclerosis	9.06e-06	3.86e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CG—atherosclerosis	8.97e-06	3.83e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NOS3—atherosclerosis	8.66e-06	3.7e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARG—atherosclerosis	8.66e-06	3.69e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—INS—atherosclerosis	8.49e-06	3.62e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—atherosclerosis	8.44e-06	3.6e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCA1—atherosclerosis	8.16e-06	3.48e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—atherosclerosis	7.92e-06	3.38e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NOS3—atherosclerosis	7.45e-06	3.18e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HMOX1—atherosclerosis	7e-06	2.99e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—atherosclerosis	6.81e-06	2.91e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOB—atherosclerosis	6.7e-06	2.86e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.52e-06	2.78e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LPL—atherosclerosis	6.4e-06	2.73e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPX1—atherosclerosis	6.24e-06	2.66e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CD36—atherosclerosis	6.08e-06	2.59e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.76e-06	2.46e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARA—atherosclerosis	5.65e-06	2.41e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AGT—atherosclerosis	5.48e-06	2.34e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOE—atherosclerosis	5.36e-06	2.29e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CAV1—atherosclerosis	5.32e-06	2.27e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOA1—atherosclerosis	5.3e-06	2.26e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.84e-06	2.07e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARG—atherosclerosis	4.67e-06	1.99e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—INS—atherosclerosis	4.58e-06	1.96e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALB—atherosclerosis	4.2e-06	1.79e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NOS3—atherosclerosis	4.02e-06	1.71e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—atherosclerosis	3.98e-06	1.7e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.68e-06	1.57e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—atherosclerosis	3.42e-06	1.46e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—atherosclerosis	1.85e-06	7.88e-06	CbGpPWpGaD
